Inhibition of hepatic drug-metabolizing enzymes by pyridoxine-5-disulfide 2HCl-2H 2 O(pyrithioxine).
D000429:Alcohol Oxidoreductases / Q000037:antagonists & inhibitors; D000596:Amino Acids / Q000378:metabolism; D000632:Aminopyrine / Q000378:metabolism; D000818:Animals; D002247:Carbon Isotopes; D003580:Cytochromes / Q000032:analysis; D004357:Drug Synergism; D004791:Enzyme Inhibitors; D005260:Female; D005954:Glucosephosphate Dehydrogenase / Q000037:antagonists & inhibitors; D006591:Hexobarbital / Q000378:metabolism; D007700:Kinetics; D008297:Male; D008614:Meperidine / Q000378:metabolism; D000432:Methanol / Q000494:pharmacology*; D051379:Mice; D008862:Microsomes, Liver / Q000032:analysis / Q000187:drug effects / Q000201:enzymology* / Q000378:metabolism; D009574:Nitro Compounds / Q000378:metabolism; D010847:Picolines / Q000494:pharmacology*; D011343:Procaine / Q000378:metabolism; D014176:Protein Biosynthesis; D051381:Rats; D012737:Sex Factors; D012890:Sleep / Q000187:drug effects; D013440:Sulfides / Q000494:pharmacology*; D013450:Sulfones / Q000494:pharmacology; D013454:Sulfoxides / Q000494:pharmacology; D013997:Time Factors
D000596:Amino Acids; D002247:Carbon Isotopes; D003580:Cytochromes; D004791:Enzyme Inhibitors; D009574:Nitro Compounds; D010847:Picolines; D013440:Sulfides; D013450:Sulfones; D013454:Sulfoxides; D000632:Aminopyrine; D011343:Procaine; D008614:Meperidine; D006591:Hexobarbital; D000429:Alcohol Oxidoreductases; D005954:Glucosephosphate Dehydrogenase; D000432:Methanol